Navamedic Secures Final Approvals for Flexilev® in All Nordic Countries Navamedic ASA proudly announces it has achieved final approvals necessary for the launch of Flexilev® in the Nordic nations. This marks a significant step towards personalized Parkinson's treatment.

Navamedic Secures Final Approvals for Flexilev® in All Nordic Countries #Norway #Oslo #Navamedic_ASA #OraFID #Flexilev

Navamedic ASA Celebrates First Approval of Innovative Medical Device OraFID® for Pharmaceuticals Navamedic ASA has received the green light for its medical device, OraFID®, marking a significant advancement in pharmaceutical delivery systems for personalized treatments.

Navamedic ASA Celebrates First Approval of Innovative Medical Device OraFID® for Pharmaceuticals #Norway #Oslo #Navamedic #OraFID #Flexilev